CAS: 1252594-99-2 - ETP-46321
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | ETP-46321 REF: TM-TQ0229CAS: 1252594-99-2 | 99.80% | 50.00 €~2,026.00 € | Tue 10 Dec 24 |
 | ETP-46321 REF: 3D-CAC59499CAS: 1252594-99-2 | Min. 95% | To inquire | Mon 13 Jan 25 |
ETP-46321
CAS:1252594-99-2
ETP-46321 is an effective and orally bioavailable PI3Kα/PI3Kδ inhibitor (Ki: 2.3/14.2 nM).
Formula:
C20H27N9O3S
Purity:
99.80%
Color and Shape:
Solid
Molecular weight:
473.55
Ref: TM-TQ0229
| 1mg | 50.00 € | ||
| 5mg | 107.00 € | ||
| 10mg | 169.00 € | ||
| 25mg | 309.00 € | ||
| 50mg | 432.00 € | ||
| 100mg | 593.00 € | ||
| 200mg | 803.00 € | ||
| 1mL*10mM (DMSO) | 113.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
ETP-46321
CAS:1252594-99-2
ETP-46321 is an imidazopyrazine that inhibits the activity of the enzyme phosphatase 2A, which is …
Formula:
C20H27N9O3S
Purity:
Min. 95%
Molecular weight:
473.55 g/mol
Ref: 3D-CAC59499
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
